echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Three drugs selected for the WHO's new crown "Solidarity Test+" project

    Three drugs selected for the WHO's new crown "Solidarity Test+" project

    • Last Update: 2021-08-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Xinhua News Agency, Geneva, August 11th.


    The WHO issued a communiqu on the same day that the three drugs were selected by an independent panel of experts and believed that they have the potential to reduce the risk of death in hospitalized patients with the new crown


    In March 2020, the World Health Organization launched the "Solidarity Test" project, which aims to find effective new crown treatments as soon as possible by comparing the safety and effectiveness of different drugs or drug combinations


    The new phase of the "Unity Test" project was named "Unity Test+", involving more than 600 hospitals from 52 countries and regions


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.